Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-036459
Filing Date
2017-05-31
Accepted
2017-05-31 16:35:04
Documents
2
Period of Report
2017-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2148
2 POA DOCUMENT poa.txt EX-24.3_727834 4186
  Complete submission text file 0001209191-17-036459.txt   7628
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Scadden David (Reporting) CIK: 0001707715 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36014 | Film No.: 17881540